FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series B / Health care startups that raised Series B in Switzerland

Health care startups that raised Series B in Switzerland

Updated 16 Nov 2026

Reset
Health care startups that raised Series B in Switzerland
One-time CSV
  • 51 funded companies, 35 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-b~switzerland.csv51 rows × 18 columns
CompanyCityLast roundAmountDate
Laza MedicalPfaffikonSeries B$160.0M2026-11-04
NovaGo TherapeuticsSchlierenSeries B$29.7M2026-08-31
Vaderis TherapeuticsBaselSeries B$152.0M2026-08-11
Windward BioBaselSeries B$165.0M2026-05-04
GlycoEraWädenswilSeries B$130.0M2025-05-27
Noema PharmaBaselSeries B$147.2M2024-12-11
RetinaiBernSeries B$7.8M2024-10-16
Lymphatica MedtechEcublensSeries B$19.6M2024-10-08

8 rows of the CSV in 5 of its 18 columns.

51
Startups
$2.4B
Total raised
7
Funded in the last 12 months
$578.3M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

22 of 51
22 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Laza Medical Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. Artificial intelligence Pfaffikon Series B $160.0M 2026-11-04 $196.0M Page One Ventures, Unorthodox Ventures, The Capital Partnership 1 to 10 2020
NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
GlycoEra GlycoEra researches and produces extracellular protein degraders for treating autoimmune diseases. Biotech Wädenswil Series B $130.0M 2025-05-27 $179.3M Sofinnova Partners, Bristol-Myers Squibb, 5AM Ventures +1 11 to 50 2020
Noema Pharma Noema Pharma develops therapies that treat disabling symptoms of brain and nervous system conditions. Biotech Basel Series B $147.2M 2024-12-11 $316.5M Polaris Partners, Sofinnova Partners, Invus +2 11 to 50 2019
Retinai RetinAI is a company that simplifies clinic, research, and pharmaceutical workflows to improve healthcare. Artificial intelligence Bern Series B $7.8M 2024-10-16 $16.8M Venture Kick, Verve Ventures, Matterwave Ventures 11 to 50 2016
CorFlow Therapeutics CorFlow Therapeutics develops proprietary technologies to diagnose and treat microvascular obstructions. Biotech Baar Series B $48.5M 2024-09-10 $66.1M Innosuisse, Unorthodox Ventures, Panakes Partners +2 11 to 50 2016
iOnctura iOnctura is a clinical-stage biotechnology company developing treatments for cancer. Biotech Geneva Series B $85.7M 2024-06-20 European Innovation Council, M Ventures, VI Partners +2 11 to 50 2017
Hemotune Hemotune develops a therapeutic blood purification platform for treating health conditions. Biotech Schlieren Series B $15.6M 2024-03-25 Venture Kick, Innosuisse, Gebert Rüf Stiftung 11 to 50 2016
Aeris Health Aeris Health provides smart solutions for monitoring and improving indoor air quality. Health care Zug Series B $8.5M 2021-03-01 $12.8M PreAngel, Sarona Ventures 11 to 50 2014
Amal Therapeutics Amal Therapeutics SA is a privately held Swiss and German biotech startup spun off from the University of Geneva. Biotech Geneva Series B $32.6M 2018-11-12 HTGF (High-Tech Gruenderfonds), Venture Kick, VI Partners +2 11 to 50 2012
Therachon Therachon is a global biotechnology company developing medicines for rare genetic diseases. Biotech Basel Series B $60.0M 2018-08-09 $100.0M Bpifrance, New Enterprise Associates, OrbiMed +2 1 to 10 2014
KB Medical KB Medical is a Swiss company that designs, develops, and commercializes the AQrate robotic system. Hardware Lausanne Series B $2.5M 2016-10-25 Venture Kick, Foundation for Innovation and Technology (FIT), Kinled Holding 1 to 10 2012
Cardiorentis Cardiorentis is a privately owned biopharmaceutical company. Biotech Zug Series B $60.4M 2016-01-10 HealthCare Royalty Partners 1 to 10 2010
Covagen Covagen develops protein-based therapeutics for inflammatory diseases and cancer. Biotech Schlieren Series B $66.1M 2013-12-09 Ventech, Novartis Venture Fund, Andera Partners +2 11 to 50 2007
Mind-NRG Mind-NRG develops peptidic neurotrophic factors for psychiatric and neurologic diseases. Biotech Geneva Series B $7.9M 2013-09-04 Index Ventures, Limburgse Reconversie Maatschappij 1 to 10 2010
Pearltec AG Pearltec provides placement, positioning, and fixation solutions for patients in research imaging studies. Health care Schlieren Series B $2.0M 2012-07-23 Tugboat 1 to 10 2008
Okairos Okairos develops genetic T-cell vaccines, including candidates targeting hepatitis C virus. Biotech Basel Series B $20.5M 2010-09-14 $30.1M EQT Life Sciences, Versant Ventures, Novartis Venture Fund +2 1 to 10 2007
ESBATech ESBATech develops fully human antibody fragments for therapeutic applications using the single-chain antibody framework. Biotech Schlieren Series B $22.0M 2008-08-07 Novartis Venture Fund, VI Partners, SV Health Investors +2 51 to 100 1998
Vivendy Therapeutics Vivendy Therapeutics develops enzyme replacement therapies. Biotech Basel Series B $30.5M 2008-06-23 EQT Life Sciences, BioMedPartners, TVM Capital +1 11 to 50 2006
PregLem PregLem is a Swiss biopharmaceutical company that develops and commercializes new drugs. Biotech Geneva Series B $32.2M 2007-12-04 $58.2M Sofinnova Partners, Sofinnova Investments, MVM Life Science Partners +1 11 to 50 2006

Table 1. Health care startups that raised Series B in Switzerland: the 22 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 51.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
2 Laza Medical Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. Artificial intelligence Pfaffikon Series B $160.0M 2026-11-04 $196.0M Page One Ventures, Unorthodox Ventures, The Capital Partnership 1 to 10 2020
3 Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
4 NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015

Table 2. Health care startups that raised Series B in Switzerland: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Venture Kick Startup incubator Schlieren, Switzerland 8 16%
2 Innosuisse Government investment office Berne, Switzerland 4 8%
3 VI Partners Venture capital firm Altendorf, Switzerland 4 8%
4 Sofinnova Partners Venture capital firm Paris, France 3 6%
5 Verve Ventures Venture capital firm Zug, Switzerland 3 6%
6 BioMedPartners Venture capital firm Basel, Switzerland 3 6%
7 Novartis Venture Fund Corporate venture arm Basel, Switzerland 3 6%
8 Unorthodox Ventures Family office Austin, United States 2 4% 1 Laza Medical
9 Kinled Holding Private equity firm New York, United States 2 4% 1 NovaGo Therapeutics
10 Novo Holdings Corporate venture arm Hellerup, Denmark 2 4% 1 Windward Bio
11 OrbiMed Private equity firm New York, United States 2 4% 1 Windward Bio
12 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany 2 4%
13 StartAngels Network Angel group Zürich, Switzerland 2 4%
14 Boehringer Ingelheim Venture Fund Corporate venture arm Ingelheim Am Rhein, Germany 2 4%
15 Versant Ventures Venture capital firm Menlo Park, United States 2 4%

Table 3. Health care startups that raised Series B in Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 30 59% $1.6B
Software 8 16% $291.0M
Hardware 4 8% $61.0M
Artificial intelligence 3 6% $273.8M
Commerce 1 2% $8.5M
Education 1 2%

Table 4. Health care startups that raised Series B in Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 51 100% $25.9M

Table 5. Health care startups that raised Series B in Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Basel 8 16%
Zürich 6 12%
Schlieren 5 10%
Lausanne 4 8%
Geneva 4 8%
Zug 3 6%
Neuchâtel 2 4%
Bern 2 4%
Epalinges 2 4%
Pfaffikon 1 2%
Wädenswil 1 2%
Ecublens 1 2%

Table 6. Health care startups that raised Series B in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 14% $160.0M
August 2026 2 29% $181.7M
July 2026 2 29% $38.0M
May 2026 2 29% $198.6M

Table 7. Health care startups that raised Series B in Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 7 14% $578.3M
2025 3 6% $206.0M
2024 9 18% $477.2M
2023 1 2% $5.1M
2022 3 6% $5.1M
2021 2 4% $128.2M

Table 8. Health care startups that raised Series B in Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 1 2%
2020 to 2022 7 14%
2015 to 2019 13 25%
2010 to 2014 14 27%
Before 2010 16 31%

Table 9. Health care startups that raised Series B in Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 17 33%
11 to 50 25 49%
51 to 100 5 10%
101 to 250 3 6%
1,001 to 5,000 1 2%

Table 10. Health care startups that raised Series B in Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Switzerland whose last round is Series B are on the list?
51, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 51 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series B in Switzerland: 51 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in Switzerland

Other sectors that raised Series B in Switzerland

Cite: FundingWatcher, 51 health care companies in Switzerland whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-b/switzerland/